Form 8-K - Current report:
SEC Accession No. 0001193125-21-267331
Filing Date
2021-09-08
Accepted
2021-09-08 08:18:56
Documents
14
Period of Report
2021-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d228933d8k.htm   iXBRL 8-K 25921
2 EX-99.1 d228933dex991.htm EX-99.1 7008
6 GRAPHIC g228933dsp1.jpg GRAPHIC 3766
  Complete submission text file 0001193125-21-267331.txt   164805

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210908.xsd EX-101.SCH 2923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210908_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210908_pre.xml EX-101.PRE 11428
7 EXTRACTED XBRL INSTANCE DOCUMENT d228933d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211240760
SIC: 2834 Pharmaceutical Preparations